Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
92,607,412
-
Share change
-
+13,083,328
-
Total reported value
-
$7,683,091,727
-
Put/Call ratio
-
78%
-
Price per share
-
$83.00
-
Number of holders
-
734
-
Value change
-
+$1,097,278,517
-
Number of buys
-
311
-
Number of sells
-
295
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2022
As of 31 Dec 2022,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
734 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,607,412 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, CITIGROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, MOORE CAPITAL MANAGEMENT, LP, JPMORGAN CHASE & CO, BROWN ADVISORY INC, Alaska Permanent Fund Corp, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, and Clal Insurance Enterprises Holdings Ltd.
This page lists
735
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.